{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:56:34Z","timestamp":1791294994750,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":709,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.bbmt.2013.01.007","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T02:01:17Z","timestamp":1358388077000},"page":"735-740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Molecular Monitoring of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia"],"prefix":"10.1016","volume":"19","author":[{"given":"Mario","family":"Arpinati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Tolomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Bochicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Castagnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Amabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Stanzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianantonio","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.01.007_bib1","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood.V83.11.3377.3377","article-title":"Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse","volume":"83","author":"van Rhee","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.007_bib2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.2009.26.7757","article-title":"Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase","volume":"28","author":"Goldman","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.01.007_bib3","first-page":"653","article-title":"Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation","volume":"85","author":"Martinelli","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.01.007_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"Hughes","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.007_bib5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V87.4.1549.bloodjournal8741549","article-title":"Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction","volume":"87","author":"Hochhaus","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.007_bib6","first-page":"1072","article-title":"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation","volume":"85","author":"Rom\u00e1n","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.01.007_bib7","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/sj.leu.2401566","article-title":"Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR","volume":"13","author":"Emig","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.01.007_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3816\/CLML.2010.n.026","article-title":"First-line therapy for chronic myeloid leukemia: new horizons and an update","volume":"10","author":"Saglio","year":"2010","journal-title":"Clin Lymph Myel Leuk"},{"key":"10.1016\/j.bbmt.2013.01.007_bib9","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1182\/blood-2005-08-3320","article-title":"Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy","volume":"107","author":"Kaeda","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.007_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1705180","article-title":"Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT)","volume":"36","author":"Cummins","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ctrv.2010.03.004","article-title":"Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited","volume":"36","author":"Deol","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bbmt.2013.01.007_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbmt.2009.11.026","article-title":"Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Wright","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib13","doi-asserted-by":"crossref","first-page":"357093","DOI":"10.1155\/2009\/357093","article-title":"The use of imatinib mesylate as a lifesaving treatment of chronic myeloid leukemia relapse after bone marrow transplantation","volume":"2009","author":"Conchon","year":"2009","journal-title":"J Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1705554","article-title":"Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis","volume":"39","author":"Palandri","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib15","first-page":"509","article-title":"Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation","volume":"12","author":"Gratwohl","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bmt.1704138","article-title":"Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML","volume":"32","author":"Bonifazi","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.01.007_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2013.01.007_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/annonc\/mdj106","article-title":"Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients","volume":"17","author":"Martinelli","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2013.01.007_bib20","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.01.007_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1751-553X.2009.01198.x","article-title":"Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients","volume":"32","author":"Ballestrero","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.bbmt.2013.01.007_bib22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/10428190109097712","article-title":"Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission","volume":"42","author":"Kitzis","year":"2001","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.bbmt.2013.01.007_bib23","first-page":"173","article-title":"Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia","volume":"85","author":"Rom\u00e1n","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.01.007_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.leu.2404170","article-title":"Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia","volume":"20","author":"Asnafi","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.01.007_bib25","first-page":"993","article-title":"Significance of quantitative detection of bcr-abl mRNA in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplant","volume":"15","author":"Geng","year":"2007","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.bbmt.2013.01.007_bib26","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.leu.2401426","article-title":"Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a \u2018real time\u2019 quantitative RT-PCR assay","volume":"13","author":"Preudhomme","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.01.007_bib27","first-page":"201","article-title":"Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results","volume":"14","author":"Miyamura","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib28","first-page":"201","article-title":"Detection of bcr\/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation","volume":"81","author":"Santini","year":"1996","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.01.007_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0145-2126(01)00109-6","article-title":"Estimations of BCR-ABL\/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion","volume":"26","author":"Otaz\u00fa","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2013.01.007_bib30","first-page":"609","article-title":"Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia","volume":"14","author":"van Rhee","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib31","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","article-title":"The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease","volume":"92","author":"Bose","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.007_bib32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood.V95.2.404","article-title":"Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation","volume":"95","author":"Chomel","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.007_bib33","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1182\/blood-2010-08-300376","article-title":"High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells","volume":"117","author":"Quintarelli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.007_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1704157","article-title":"ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)","volume":"32","author":"Zander","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1704135","article-title":"Dose-dependent effects of in\u00a0vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML","volume":"32","author":"Schleuning","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.bmt.1703530","article-title":"In\u00a0vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors","volume":"29","author":"Kr\u00f6ger","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bbmt.2010.07.023","article-title":"Individualized intervention guided by BCR-ABL transcript levels after HLA-identical sibling donor transplantation improves HSCT outcomes for patients with chronic myeloid leukemia","volume":"17","author":"Huang","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.bmt.1704386","article-title":"Preemptive treatment of minimal residual disease post transplant in CML using real-time quantitative RT-PCR: a prospective, randomized trial","volume":"33","author":"Kim","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib39","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood.V99.10.3861","article-title":"Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation","volume":"99","author":"Olavarria","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.007_bib40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.bmt.1703222","article-title":"Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation","volume":"28","author":"Wassmann","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.007_bib41","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2002-09-2932","article-title":"Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML","volume":"101","author":"McCann","year":"2003","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:45:05Z","timestamp":1761057905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1083879113000220"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.007","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Monitoring of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}